Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
ReplyCorrespondence

Dr. Erdozain, et al reply

JOSE GABRIEL ERDOZAIN, IRAMA VILLAR, JAVIER NIETO and GUILLERMO RUIZ-IRASTORZA
The Journal of Rheumatology October 2014, 41 (10) 2086; DOI: https://doi.org/10.3899/jrheum.140442
JOSE GABRIEL ERDOZAIN
Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IRAMA VILLAR
Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAVIER NIETO
Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GUILLERMO RUIZ-IRASTORZA
Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: r.irastorza@euskaltel.net
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

To the Editor:

We thank Dr. Kawada1 for his interest in our study2 and acknowledge his comments, which we will try to address.

Regarding the first issue, the prevalence of ankle brachial index (ABI) > 1.4 in our cohort was low: 2.77% (6/216 patients). It is true that high ABI values, with a cutoff value ranging between 1.3 and 1.4, have been related with higher cardiovascular mortality. The Strong Heart Study found a similar association between cardiovascular mortality and both high ABI and low ABI, although this study may be biased by the fact that it was conducted in an American Indian population3. However, the evidence of cardiovascular mortality and morbidity related with low ABI is very strong, and given the number of patients with high ABI in our study, we do not think the inclusion as controls of individuals with high ABI invalidates our results.

Dr. Kawada raises his concerns about the possibility of false-positive low ABI values given the low number of symptomatic patients in our cohort. However, it is well known that, in the general population, most patients with peripheral arterial disease (PAD) are asymptomatic4, and our figures fit with these data. In fact, ABI has been developed as a screening test for PAD in asymptomatic individuals5.

We agree that our sample size was somewhat small for an extensive logistic regression analysis to be performed. Thus, only those variables with p values ≤ 0.1 in the univariant analysis were included in the initial model. Indeed, many of them were intimately related (age at diagnosis and at the time of the study, several cardiovascular risk factors alone or in combination). Finally, only the age at study was fully significant. However, the combination of diabetes mellitus, hypertension, hypercholesterolemia, or current smoking was borderline significant, with an OR 2.3, 95% CI 0.99–5.1, p = 0.053, which makes clinical sense.

We agree with Dr. Kawada that a more sizeable study group would help reduce CI and make the results stronger; yet, we believe that our data, despite the limitations, represent a significant contribution to the study of this underdiagnosed condition in patients with systemic lupus erythematosus.

REFERENCES

  1. 1.↵
    1. Kawada T
    . Predictive factors for low ankle brachial index in patients with systemic lupus erythematosus. J Rheumatol 2014;41:2086.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Erdozain JG,
    2. Villar I,
    3. Nieto J,
    4. Ruiz-Irastorza G
    . Peripheral arterial disease in systemic lupus erythematosus: prevalence and risk factors. J Rheumatol 2014;41:310–7.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Resnick HE,
    2. Lindsay RS,
    3. McDermott MM,
    4. Devereux RB,
    5. Jones KL,
    6. Fabsitz RR,
    7. et al.
    Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004;109:733–9.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Hirsch AT,
    2. Criqui MH,
    3. Treat-Jacobson D,
    4. Regensteiner JG,
    5. Creager MA,
    6. Olin JW,
    7. et al.
    Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317–24.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. McDermott MM,
    2. Criqui MH,
    3. Liu K,
    4. Guralnik JM,
    5. Greenland P,
    6. Martin GJ,
    7. et al.
    Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg 2000;32:1164–71.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 10
1 Oct 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dr. Erdozain, et al reply
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Dr. Erdozain, et al reply
JOSE GABRIEL ERDOZAIN, IRAMA VILLAR, JAVIER NIETO, GUILLERMO RUIZ-IRASTORZA
The Journal of Rheumatology Oct 2014, 41 (10) 2086; DOI: 10.3899/jrheum.140442

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Dr. Erdozain, et al reply
JOSE GABRIEL ERDOZAIN, IRAMA VILLAR, JAVIER NIETO, GUILLERMO RUIZ-IRASTORZA
The Journal of Rheumatology Oct 2014, 41 (10) 2086; DOI: 10.3899/jrheum.140442
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Dr. Kitajima et al reply
  • Dr. Putman et al reply
  • Drs. Chung and McMahan reply
Show more Correspondence

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire